Please login to the form below

Not currently logged in
Email:
Password:

Vaccine

This page shows the latest Vaccine news and features for those working in and with pharma, biotech and healthcare.

BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

From a strategic standpoint, the new site will bolster our vertically integrated business model with in-house manufacturing capabilities for mRNA manufacturing as well as vaccine formulation,” he added. ... The initiative is focused on expanding the

Latest news

More from news
Approximately 124 fully matching, plus 1,131 partially matching documents found.

Latest Intelligence

  • The flexible salesforce The flexible salesforce

    waves of new cases. With widespread availability of effective vaccines still some way off, many countries find themselves in a phase before the ‘new normal’, where mitigation actions continue to change

  • Exploiting the value of data in pharma Exploiting the value of data in pharma

    the world’s leading pharma companies ‘to accelerate the development, manufacture and delivery of vaccines, diagnostics and treatments for COVID-19’. ... Accelerate development. Again, in March, the Innovative Medicines Initiative (IMI) issued a

  • What’s next? How behavioural science can support pharma’s future What’s next? How behavioural science can support pharma’s future

    behaviour. Vaccines to protect against a range of diseases are likely to be more widely and more quickly adopted, by all customer types.

  • A new era for patient services? A new era for patient services?

    Importantly, the role industry is playing in leading efforts to find and manufacture effective COVID-19 treatments and a vaccine will likely have a positive impact on public and healthcare system

  • Why pharma must trust the science of behaviour Why pharma must trust the science of behaviour

    In the absence of a treatment or vaccine, behaviour change remains our best hope of thwarting COVID-19. ... However, while we await a vaccine, those behaviours are currently the best weapon we have.

More from intelligence
Approximately 6 fully matching, plus 105 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 63 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 41 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...

Infographics